At BD, we offer a broad portfolio of fully integrated solutions to address your needs. Our goal is to be your strategic partner throughout your combination product development journey.
true
Drug Delivery Systems
Made for what’s next in drug delivery. Our vision is to enable customer success with high quality and innovative drug delivery solutions that improve patient well-being.
- Overview
- Products & Services
- Pharmaceutical Needs
- Therapeutic Areas
- News & Events
- Contact Us
Introducing Drug Delivery Systems
Innovative design, global manufacturing, product development expertise
With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.
At a glance…
-
>3Bn
Prefillable Syringes* (PFS) manufactured per year1
-
$2Bn
Yearly revenue (2022)**
-
7500
Associates globally
-
8
Manufacturing plants worldwide
-
Global Headquarters
in Pont-de-Claix, France
Products used by more than 500 Pharmaceutical and Biotechnology companies.2
BD customers include 27 of the top 30 pharmaceutical companies in the world.3
~70% of the top 100 pharmaceutical companies around the world rely BD Medical-Pharmaceutical Systems prefillable drug-delivery systems for a wide variety of therapeutic applications.4
BD has generated over 4000 patents that are enforced in more than 25 countries.5
We are focusing on patient well-being
There is a patient at the end of each of the billions of drug delivery devices that we make at BD. That is why we have invested in deep knowledge around patient experience, injection science and combination product development to anticipate customer challenges, manage complexities, and reduce risks. We also invest heavily to support our commitment to quality. Through our extensive global manufacturing network, we aim to offer security of supply and business continuity to our customers.
These, plus our ability to leverage the industry and health authority partnerships of a global healthcare company, are game changing advantages that BD brings to our customers’ drug delivery challenges.
We leverage these assets as we develop innovative solutions that provide peace of mind to customers and contribute to greater patient well-being.
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
Prefillable syringe systems
Featuring a comprehensive portfolio of innovative prefillable syringe systems, BD offers drug delivery solutions designed to help decrease development risk, improve speed to market, and increase flexibility to meet patients’ needs across a wide range of drug types and therapeutic areas.
Explore our prefillable syringes
Safety and shielding systems
BD Safety & Shielding Systems provide pharmaceutical companies with a wide range of both active and passive manual injection solutions available in 0.5ml, 1ml, and 2.25ml formats, suitable for a variety therapeutic indications.
Explore our safety and shielding devices
Self-injection systems
BD offers an extensive portfolio of patient centric, self-administered drug delivery solutions including disposable autoinjectors, disposable variable dose pen injectors, and wearable injectors designed to deliver a wide range of volumes and viscosities and help de-risk combination product development.
Explore our self-injection systems
Plunger stoppers
BD is a supplier of ready-to-use plunger stoppers for prefillable syringes (PFS)1, providing over 12 billion PFS plunger stoppers to 700+ customers since 2022.2 We offer a variety of plunger stoppers covering a range of formulations, so you can choose one that’s right to deliver your drug combination product.
Explore our Plunger Stoppers
Backstops and plunger rods
As part of our integrated approach to help you develop drug combination products, we offer BD Backstops and BD Plunger Rods in a range of sizes, materials and colors. Designed so you can complete your PFS system based on your particular specifications.
Explore our Backstops and plunger rods
A history of innovation and market leadership
2022
BD Effivax™ Glass Prefillable Syringe
2021
BD SCF™ PremiumCoat® Plunger Stopper
2021
BD Libertas™ Wearable Injector
2021
BD Evolve™ On-body Injector
2021
BD Neopak™ XtraFlow™ Glass Prefillable Syringe
2019
ZebraSci combination product services
2018
BD Hylok™ Glass Prefillable Syringe
2018
BD Neopak™ XSi™ Glass Prefillable Syringe
2014
BD Hypak™ for Vaccines Glass Prefillable Syringe
2013
BD UltraSafe Plus™ 1mlL Passive Needle Guard
2013
BD Sterifill Advance™ 50ml Polymer Prefillable Syringe
2013
BD Neopak™ Glass Prefillable Syringe
2012
BD acquires Safety Syringes Inc.
2012
BD Vystra™ Disposable Pen
2011
BD AutoShield Duo™ Safety Pen Needle
2010
BD Physioject™ Disposable Autoinjector
2009
BD Hypak™ for Biotech Glass Prefillable Syringe
2004
BD Hypak Physiolis™ Glass Prefillable Syringe
2003
BD Sterifill™ Polymer Prefillable Syringe
2001
BD Eclipse™ Needle Shielding System
2000
BD Accuspray™ Nasal Spray System
2000
BD SCF™ FluroTec® Plunger Stoppers
1998
5-bevel needle
1998
BD Uniject™ Auto-Disable Prefillable Injection System
1996
BD Sterifill™ Polymer Prefillable Syringe
1996
BD SafetyGlide™ Needle Shielding System
1990
Polypropylene corrugated materials
1975
First SCF Filling process
1954
BD Hypak™ Glass Disposable Syringe
Honors and Recognition
2022 - Ease of Use℠ Award
BD Physioject™ - recognized by the Arthritis Foundation®
2021 – Vaccine Industry Excellence
Best Production/Process Development
2021 – Frost & Sullivan
BD Intevia™ - Best Practices Award
2020 – Derwent
Top 100 Global Innovator
2019 – Good Design® Award
BD Libertas™ wins prestigious Good Design® Award
2015 – Thomson Reuters
Top 100 Global Innovators
2015 – PDMA OCI
Outstanding Corporate Innovator
2015 – Fortune
World’s Most Admired Companies
* PFS containers
** BD Annual report 2022
BDM-PS Financial file November 2022, “Actual FY22” Permiter.
BDM-PS Financial file November 2020, "Actual FY20" Permiter.
BD Customers compared to Evaluate Pharma ranking FY2019
IQVIA: IQVIA dataset extracted on March 11th, 2021, from the IQVIA Smart MIDAS' on-line platform, includes WW sales of injectable drugs. Top 100 Corporation (based on IQVIA standard units 2020) selling PFS, Autoinjectors or Pens. TA included: Acute biologics, Anticoagulants, Chronic, Small molecules, Vaccines
BDM-PS Patents – In force – Worldwide – October 2021.
Solutions to meet your needs across
therapeutic areas
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery
systems to pharmaceutical and biotech companies.
Advanced Drug Delivery Solutions and Strategic Partnerships
Explore the PartnerPath™ Program and our services to understand how we can support your pharmaceutical advancements and strategic initiatives.
BD PartnerPath™ Program
BD PartnerPath™ supports the development of combination products, with quick access to small quantities of preconfigured drug delivery systems – delivery within 2 weeks*
Services
Partner with BD and our professional services to help you achieve your drug combination product goals, from development to launch.
*of BD confirmation of your order
Innovative Drug Delivery Systems
With over 50 years of experience, we are empowering customer success through innovative drug-delivery solutions that improve patient quality of life.
-
-
-
-
-
Our solution aims at enabling you to improve availability of the right medications for your patients by delivering a best-in-class technology to reduce fill/finish risks and improve operational efficiency.
-
Solutions to meet your needs across therapeutic areas
BD Medical - Pharmaceutical Systems manufactures and sells prefillable drug delivery systems to pharmaceutical and biotech companies.
Biologic Drugs
-
BD understands the challenges faced by pharmaceutical companies that serve people with diabetes.
-
-
Partner with BD to support your combination drug product development needs for your oncology drug.
-
Partner with BD to support your combination drug product development needs for autoimmune therapy.
Vaccines
-
Partner with BD to support the development of your combination drug product for infectious respiratory diseases.
-
BD meets the needs of pharmaceutical vaccine manufactures, from conventional inactivated vaccines to cutting-edge mRNA technology.
Anticoagulant
-
Partner with BD to bring your anticoagulant to market.
Small Molecules
-
Partner with BD to support your combination drug product development needs for analgesics and anesthetics.
-
Partner with BD to support your combination drug product development needs for cardiac therapy.
Specialty Injectables
-
A portfolio of prefillable syringe solutions to meet your product development and clinician needs within dermal fillers applications.
-
Partner with BD to support your combination drug product development needs for orthopedics.
-
Partner with BD to support your combination product development needs for Hyaluronic Acid.
Events
SAE PFS West Coast
June 8–10, 2026
San Diego, USA
Join BD and attend:
- Booth
- Keynote
Register and Learn More
PDA WW UPS
October 6–7, 2026
Palm Springs, USA
Join BD and attend:
- Booth #515
- Keynote
- Tech Talk
- Silver Sponsorship (Breakfast Day 1)
Register and Learn More
PODD
October 29–30, 2026
Boston, USA
Join BD and attend:
- Booth
- Solo Talk
- Tech Talk
- Executive Sponsorship
Register and Learn More
Pharmapack
January 27/28, 2027
Paris, France
Join BD and attend:
- Booth #4D84
- 2 Learning Lab sessions (Day 1 - 15.10 & Day 2 - 10.50)
- Large Volume Drug Delivery Conference Track Sponsorship and keynote
Register and Learn More
News and Media
-
Sep 13, 2022BD Effivax™ Glass Prefillable Syringe Features Enhanced Technology that Builds on Company’s Decades of Expertise in the Prefillable Syringe Market and Supports Customers’ Manufacturing Needs FRANKLIN LAKES, N.J. (September 13, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination and integrity.1
-
May 18, 2022Companies to work together with the aim of optimizing advanced technologies for use in prefillable syringes FRANKLIN LAKES, N.J. (May 18, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes.
true
